Variation in Treatment of Pediatric Tuberculosis Infection in Different Provider Settings - 22/08/23
, Shom Dasgupta-Tsinikas, MD 2, Josephine Yumul, MSc 2, Kelli Kaneta, MD 3, Annika Lenz, MD 4, Richard Kizzee, MD 3, Dustin Bihm, MD 3, Christina Jung, MD 5, Michael Neely, MD, MSc 1, 4, Ramon E. Guevara, MPH, PhD 2, Julie Higashi, MD, PhD 2, Jeffrey M. Bender, MD 1, 4Abstract |
Objectives |
To evaluate implementation of rifamycin-based regimens (RBR) for pediatric tuberculosis infection (TBI) treatment among 3 provider settings in a high-incidence county.
Study design |
A multicenter, retrospective observational study was performed across 3 sites in Los Angeles County: an academic center (AC), a general pediatrics federally qualified health center (FQHC), and department of public health (DPH) tuberculosis clinics. Patients initiated on TBI treatment age 1 months to 17 years between 2018 and 2020 were included. RBRs were defined as regimens: 3 months of weekly rifapentine and isoniazid, 4 months of daily rifampin, and 3 months of daily isoniazid and rifampin.
Results |
We included 424 patients: 51 from AC, 327 from DPH, and 46 from FQHC. RBR use nearly doubled during the study period (from 43% in 2018 to 82% in 2020; P < .001). FQHC had the shortest time to chest radiograph and treatment initiation; however, AC and DPH were 4 times as likely to prescribe an RBR compared to FQHC (95% CI, 2.1-7.8). AC and DPH had similar completion rates (74%) and were 2.6 times as likely to complete treatment compared to FQHC (95% CI, 1.4-4.9).
Conclusions |
The use of RBRs for pediatric TBI varies significantly by clinical setting but is improving over time. Strategies are needed to improve RBR uptake, standardize care, and increase treatment completion, particularly among general pediatricians.
Le texte complet de cet article est disponible en PDF.Keywords : infectious diseases, public health, tuberculosis elimination
Abbreviations : 3HP, 4R, 9H, AC, COVID-19, CHLA, DOT, DPH, FQHC, IBR, ICD-10, IGRA, INH, LAC, RBR, SAT, TB, TBI, TST
Plan
| The authors have no conflicts of interest relevant to this article to disclose. |
|
| Funding/Support: This project was supported by the Skirball Research Fellowship Award at Children's Hospital Los Angeles. |
Vol 259
Article 113419- août 2023 Retour au numéro
Article précédent
- Impact of Deprivation on the Incidence and Severity of Tuberculosis in Children: A Retrospective Study from 2007 to 2020 in a Tertiary Care Center in Paris, France
- Jee-Seon Yang, Morgane Michel, Haude Cogo, David Malorey, Nora Poey, Marion Caseris, Karine Chevreul, Albert Faye
- Treprostinil in Neonates with Congenital Diaphragmatic Hernia-Related Pulmonary Hypertension
- Felix R. De Bie, Catherine M. Avitabile, Sabrina Flohr, Sierra Land, Leny Mathew, Yan Wang, Devon Ash, Natalie E. Rintoul, Holly L. Hedrick
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?